William Blair & Company
CELG

William Blair & Company’s Celgene Corp CELG Stock Holding History

William Blair & Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$29K – 1483
2017
Q3 		$29K Sell
200
-200
-50% -$27.2K ﹤0.01% 1339
2017
Q2 		$52K Hold
400
– – ﹤0.01% 1467
2017
Q1 		$50K Buy
400
+100
+33% +$12K ﹤0.01% 1337
2016
Q4 		$34K Buy
+300
New +$33.4K ﹤0.01% 1276

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

William Blair & Company's CELG Position: Q4 2019 in Review

William Blair & Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 251,967 shares — an estimated $25M sold.

William Blair & Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $105M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • William Blair & Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • William Blair & Company sold 251,967 Celgene Corp shares in Q4 2019, an estimated $25M.
  • William Blair & Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • William Blair & Company's Celgene Corp position peaked at $105M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on William Blair & Company's 13F filing for Q4 2019, filed 13 Feb 2020.